Nashville Biosciences, a wholly owned subsidiary of Vanderbilt University Medical Center, was created to harness the medical center's extensive genomic and bioinformatics resources for drug and diagnostics discovery and development. Leveraging Vanderbilt University Innovation™, Nashville Biosciences serves as a commercial interface between outside companies and the formidable research capabilities housed within Vanderbilt University Medical Center, including BioVU®, one of the world’s most comprehensive genetic databases linked to de-identified medical records with years of longitudinal clinical data. This unique asset is one of the largest and highest quality of its kind, providing an unprecedented opportunity to guide R&D activity in biotech, pharma, diagnostics, medical devices and other life sciences applications.

Biotechnology

Nashville Biosciences

Leeland Ekstrom

Steven Held

Judsen Schneider

James Stover

Elizabeth Ann Stringer

The Leadership Team at Nashville Biosciences is responsible for setting the strategic direction, fostering innovative collaborations, and managing the overall operations of the company. The Chief Scientific Officer spearheads research initiatives and ensures scientific rigor. The CTO drives technological advancements and infrastructure development. The Chief Business Development Officer identifies and cultivates partnerships and business opportunities. The CEO & Co-founder oversees organizational strategies and maintains alignment with the company’s mission, leveraging Vanderbilt University Innovation™. Together, they harness the medical center's extensive genomic and bioinformatics resources to advance drug and diagnostics discovery and development.

Leadership Team

Scientific Project Management Team

Business Development

Leadership Team

About

Team members

Other teams at Nashville Biosciences

Scientific Project Management Team

Business Development